Free Trial
ASX:ANP

Antisense Therapeutics (ANP) Stock Price, News & Analysis

Antisense Therapeutics logo

About Antisense Therapeutics Stock (ASX:ANP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.32 million shs
Average Volume
N/A
Market Capitalization
A$52.29 million
P/E Ratio
N/A
Dividend Yield
4.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ANP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antisense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ANP Stock News Headlines

ANP leader, cop gunned down in Bajaur
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
ANP leader among three killed in Bajaur shooting
See More Headlines

ANP Stock Analysis - Frequently Asked Questions

Antisense Therapeutics Limited (ASX:ANP) announced its earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share (EPS) for the quarter. Antisense Therapeutics had a negative net margin of 720.31% and a negative trailing twelve-month return on equity of 73.14%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Antisense Therapeutics investors own include Tocagen (TOCA), Miragen Therapeutics (MGEN), Direxion Daily S&P Biotech Bull 3x Shares (LABU), Iovance Biotherapeutics (IOVA), Genocea Biosciences (GNCA), Capricor Therapeutics (CAPR) and Applied DNA Sciences (APDN).

Company Calendar

Last Earnings
2/27/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Consumer Goods
Current Symbol
ASX:ANP
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$11.38 million
Net Margins
-720.31%
Pretax Margin
N/A
Return on Equity
-73.14%
Return on Assets
-41.69%

Debt

Debt-to-Equity Ratio
1.42
Current Ratio
4.51
Quick Ratio
18.16

Sales & Book Value

Annual Sales
A$1.58 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
4.18
Book Value
A$0.02 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
901,550,000
Free Float
N/A
Market Cap
A$52.29 million
Optionable
Not Optionable
Beta
1.06
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (ASX:ANP) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners